Double the measures-double the benefit: Kidney Disease Screening in Coronary Heart Disease.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  European Journal of Preventive Cardiology

• Publication date

  2025-11-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurjpc/zwaf729PMID 41231724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease Results from the combined EUROASPIRE IV and V studies.

  2025cited by this paper
• KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

  2024cited by this paper
• Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease

  2024cited by this paper
• 2024 ESC Guidelines for the management of chronic coronary syndromes.

  2024cited by this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cited by this paper
• Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

  2023cited by this paper
• Epidemiology of chronic kidney disease: an update 2022.

  2022cited by this paper
• Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

  2019cited by this paper
• Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

  2019cited by this paper
• Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality.

  2001cited by this paper

• No citing papers are available for this paper.